TickerFactsScreenerDevelopers

BIO-TECHNE Corp (TECH) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $166.99M2009: $160.94M2010: $94.14M2011: $77.61M2012: $116.67M2013: $163.79M2014: $318.57M2015: $54.53M2016: $64.24M2017: $91.61M2018: $121.99M2019: $100.89M2020: $146.62M2021: $199.09M2022: $172.57M2023: $180.57M2024: $151.79M2025: $162.19M$162.19M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$162.19M+6.8%
2024$151.79M-15.9%
2023$180.57M+4.6%
2022$172.57M-13.3%
2021$199.09M+35.8%
2020$146.62M+45.3%
2019$100.89M-17.3%
2018$121.99M+33.2%
2017$91.61M+42.6%
2016$64.24M+17.8%
2015$54.53M-82.9%
2014$318.57M+94.5%
2013$163.79M+40.4%
2012$116.67M+50.3%
2011$77.61M-17.6%
2010$94.14M-41.5%
2009$160.94M-3.6%
2008$166.99M—